Data Sheet 1_Increased circulating levels of SP-D and IL-10 are associated with the development of disease severity and pulmonary fibrosis in patients with COVID-19.pdf by Xin Pan (3712768)

“…Among the biomarkers indicative of macrophage polarization, compared to non-ARDS patients, a significant increase in IL-10, Inducible nitric oxide synthase (iNOS), and Arginase-1 (Arg-1) were observed in ARDS patients, while Tumor necrosis factor-α (TNF-α) was decreased. …”

Fig 8 - by Xinyi Xia (7516694)

Subjects:

Gene expression omnibus datasets. by Xinyi Xia (7516694)

Subjects:

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Exponential phase cells express high levels of ribosomal protein genes. by Justin Greene (306625)

Subjects:

Distribution of Pre-existing Medical Conditions. by Sepideh Hejazi (16227860)

“…</p><p>Results</p><p>Initial clinical presentations differed significantly, eneralized Estimating Equations (GEE) analysis, adjusted for comorbidities, revealed COVID-19 history was associated with increased platelet counts <i>(P</i> = 0.0311) and decreased facial swelling <i>(P</i> = 0.049) and fever symptom reporting <i>(P</i> < 0.001). …”

HPD 1466 decreases empty capsid accumulation in cells replicating HBV. by Daniel P. Bradley (10306893)

(a) Absolute error of the example 3, Y(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

S1 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S3 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S2 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S5 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S6 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S4 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

S7 Data - by Renjie Wang (1986553)

“…Superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), and malondialdehyde (MDA) levels significantly increased during D1 treatment but decreased with D2 and D3 treatments. …”

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Subjects:

Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

Subjects:

Gender differences in first choice match outcomes. by Lucy Hui (17538542)

Subjects:

Total number of applications to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

Subjects: